Molecular basis of resistance to thyroid hormone

Trends in Endocrinology and Metabolism

Volumn 14, Issue 7, 2003, Pages 327-333

  Yen, Paul M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR SUBTYPE; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR A; THYROID HORMONE RECEPTOR B; THYROTROPIN; UNCLASSIFIED DRUG;

ALLELISM; CELL FUNCTION; GENE; GENE LOCUS; GENE MUTATION; GENE THRA; GENE THRB; GENETIC ENGINEERING; HORMONE ACTION; HORMONE RESISTANCE; HUMAN; IMMUNOPRECIPITATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TECHNIQUE; THYROID HORMONE BLOOD LEVEL; TRANSCRIPTION INITIATION;

EID: 0042335979     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(03)00114-0     Document Type: Review

References (66)

1. Refetoff, S. et al. (1967) Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J. Clin. Endocrinol. Metab. 27, 279-294
2. Refetoff, S. et al. (1993) The syndromes of resistance to thyroid hormone. Endocr. Rev. 14, 348-399
3. Brucker-Davis, F. et al. (1995) Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health prospective study. Ann. Intern. Med. 123, 572-583
4. Beck-Peccoz, P. and Chatterjee, V.K. (1994) The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4, 225-232
5. Gershengorn, M.C. and Weintraub, B.D. (1975) Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of 'inappropriate secretion of TSH'. J. Clin. Invest. 56, 633-642
6. Sap, J. et al. (1986) The c-erbA protein is a high affinity receptor for thyroid hormone. Nature 324, 635-640
7. Weinberger, C. et al. (1986) The c-erbA gene encodes a thyroid hormone receptor. Nature 324, 641-646
8. McKenna, N.J. et al. (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20, 321-344
9. Yen, P.M. (2001) Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81, 1097-1142
10. Zhang, J. and Lazar, M.A. (2000) The mechanism of action of thyroid hormones. Annu. Rev. Physiol. 62, 439-466
11. Wagner, R.L. et al. (1995) A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697
12. Wood, W.M. et al. (1994) Structural and functional characterization of the genomic locus encoding the murine β2 thyroid hormone receptor. Mol. Endocrinol. 8, 1605-1617
13. Bradley, D.J. et al. (1992) Spatial and temporal expression of α- and β-thyroid hormone receptor mRNAs, including the b2-subtype, in the developing mammalian system. J. Neurosci. 12, 2288-2302
14. Feng, X. et al. (2000) Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol. Endocrinol. 14, 947-955
15. Williams, G.R. and Brent, G.A. (1995) Thyroid hormone response elements. In Molecular Endocrinology: Basic Concepts and Clinical Correlations (Weintraub, B., ed.), pp. 217-239, Raven Press
16. Glass, C.K. (1994) Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocr. Rev. 15, 391-407
17. Hu, I. and Lazar, M.A. (2000) Transcriptional repression by nuclear hormone receptors. Trends Endocrinol. Metab. 11, 6-10
18. Horlein, A.J. et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear co-repressor. Nature 377, 397-404
19. Chen, J.D. and Evans, R.M. (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454-457
20. Onate, S.A. et al. (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357
21. Torchia, J. et al. (1998) Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10, 373-383
22. Ito, M. and Roeder, R.G. (2001) The TRAP/SMCC/mediator complex and thyroid hormone receptor function. Trends Endocrinol. Metab. 12, 127-134
23. Rachez, C. and Freedman, L.P. (2001) Mediator complexes and transcription. Curr. Opin. Cell Biol. 13, 274-280
24. Sharma, D. and Fondell, J.D. (2002) Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc. Natl. Acad. Sci. U. S. A. 99, 7934-7939
25. Shang, Y. et al. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852
26. Usala, S.J. et al. (1988) Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbAb gene. Mol. Endocrinol. 2, 1217-1220
27. Sakurai, A. et al. (1989) Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor β. Proc. Natl. Acad. Sci. U. S. A. 86, 8977-8981
28. Usala, S.J. et al. (1990) A base mutation of the c-erbAb thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J. Clin. Invest. 85, 93-100
29. Weiss, R.E. and Refetoff, S. (2000) Resistance to thyroid hormone. Rev. Endocr. Metab. Disord. 1, 97-108
30. Takeda, K. et al. (1992) Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-β gene. J. Clin. Endocrinol. Metab. 74, 49-55
31. Yen, P.M. and Chin, W.W. (1994) Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol. Endocrinol. 8, 1450-1454
32. Zhang, X.Y. et al. (2002) Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant β receptor. Mol. Endocrinol. 16, 2077-2092
33. Ono, S. et al. (1991) Homozygosity for a dominant negative thyroid hormone receptor responsible for generalized thyroid hormone resistance. J. Clin. Endocrinol. Metab. 73, 990-994
34. Yen, P.M. et al. (1992) New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone. J. Clin. Invest. 90, 1825-1831
35. Nagaya, T. et al. (1992) Thyroid hormone receptor mutants that cause resistance to thyroid hormone: evidence for receptor competition for DNA sequences in target genes. J. Biol. Chem. 27, 13014-13019
36. Nagaya, T. and Jameson, J.L. (1993) Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J. Biol. Chem. 268, 15766-15771
37. Hayashi, Y. et al. (1995) Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-β receptors? J. Clin. Endocrinol. Metab. 80, 3246-3256
38. Collingwood, T.N. et al. (1994) Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone β-receptors in thyroid hormone resistance syndrome. Mol. Endocrinol. 8, 1261-1277
39. Flynn, T.R. et al. (1994) A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J. Biol. Chem. 269, 32713-32716
40. Nagaya, T. et al. (1993) Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J. Clin. Endocrinol. Metab. 77, 982-990
41. Hao, E. et al. (1994) Divergent dimerization properties of mutant TRβ1 thyroid hormone receptors are associated with different dominant negative activities. Mol. Endocrinol. 8, 841-851
42. Meier, C.A. et al. (1992) Variable transcriptional activity and ligand binding of mutant β1-3,5,3′ triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol. Endocrinol. 6, 248-258
43. Collingwood, T.N. et al. (1997) A natural transactivation mutation in the thyroid hormone β receptor: impaired interaction with putative transcriptional mediators. Proc. Natl. Acad. Sci. U. S. A. 94, 248-253
44. Tagami, T. et al. (1998) A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Mol. Endocrinol. 12, 1888-1902
45. Takeshita, A. et al. (1998) Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor-binding domains of the steroid-receptor coactivator-1. J. Biol. Chem. 273, 21554-21562
46. Liu, Y. et al. (1998) Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors. Endocrinology 139, 4197-4204
47. Clifton-Bligh, R.J. et al. (1998) A novel TR β mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation. Mol. Endocrinol. 12, 609-621
48. Yoh, S.M. et al. (1997) Thyroid hormone resistance manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol. Endocrinol. 11, 470-480
49. Safer, J.D. et al. (1998) Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone. J. Biol. Chem. 273, 30175-30182
50. Onigata, K. et al. (1995) A novel point mutation (R243Q) in exon 7 of the c-erbAb thyroid hormone receptor gene in a family with resistance to thyroid hormone. Thyroid 5, 355-358
51. Collingwood, T.N. et al. (1998) A role for helix 3 of the TRβ ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone. EMBO J. 17, 4760-4770
52. Pohlenz, J. et al. (1999) Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor β gene. J. Clin. Endocrinol. Metab. 84, 3919-3928
53. Weiss, R.E. et al. (1999) Mice deficient in the steroid receptor coactivator 1 (SRC-1) are resistant to thyroid hormone. EMBO J. 18, 1900-1904
54. Reutrakul, S. et al. (2000) Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor β or α genes. J. Clin. Endocrinol. Metab. 85, 3609-3617
55. Lin, K.-H. et al. (1996) Identification of naturally occurring dominant negative mutants of thyroid hormone a1 and β1 receptors in a human hepatocellular carcinoma cell lines. Endocrinology 137, 4073-4081
56. Yen, P.M. and Cheng, S-Y. Somatic mutations of thyroid hormone receptors and tumor development in man. J. Endocrinol. Invest. (in press)
57. Ando, S. et al. (2001) Somatic mutation of TRO can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J. Clin. Endocrinol. Metab. 86, 5572-5576
58. Wong, R. et al. (1997) Transgenic mice bearing a human mutant thyroid hormone β1 receptor manifest thyroid function anomalies, weight reduction, and hyperactivity. Mol. Med. 3, 303-314
59. Forrest, D. and Vennstrom, B. (2000) Functions of thyroid hormone receptors in mice. Thyroid 10, 41-52
60. Flamant, F. and Samarut, J. (2003) Thyroid hormone receptor: lessons from knockout and knock-in mice. Trends Endocrinol. Metab. 14, 85-90
61. Kaneshige, M. et al. (2000) Mice with a targeted mutation in the thyroid hormone β receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc. Natl. Acad. Sci. U. S. A. 97, 13209-13214
62. Suzuki, H. et al. (2002) Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12, 963-969
63. Hashimoto, K. et al. (2001) An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc. Natl. Acad. Sci. U. S. A. 98, 3998-4003
64. Kaneshige, M. et al. (2001) A targeted dominant negative mutation of the thyroid hormone α1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc. Natl. Acad. Sci. U. S. A. 98, 15095-15100
65. Tinnikov, A. et al. (2002) Retardation of post-natal development caused by a negatively acting thyroid hormone receptor α1. EMBO J. 21, 5079-5087
66. Itoh, Y. et al. (2001) Brain glucose utilization in mice with a targeted mutation in the thyroid hormone α or β receptor gene. Proc. Natl. Acad. Sci. U. S. A. 98, 9913-9918